Abstract
for adhesion receptors and stimulation of immunity [9, 10] . 48
Probiotics are usually members of the genera Lactobacillus and 49
Bifidobacterium (although some members of the genera Streptococcus, 50
Enterococcus, Lactococcus spp., Bacillus spp. and some yeast, for example 51
Saccharomyces boulardii, have been identified as probiotics). They are known 52
as members of the microbiota, which significantly contribute to a beneficial 53 health effect and have a long history of safe use [11] . Initially it was 54 anticipated that single probiotic strains from these genera or species could 55 produce the intended health benefits using the mechanisms underlined but as 56 knowledge of probiotic use has developed it is becoming clearer that for 57 optimal effect, mixed probiotics should be formulated. This resolution 58 stemmed from the basis that it was unlikely a single probiotic strain could 59 colonize the gut and achieve all therapeutic benefits and also because 60 probiotics could be used for targeting a number of diseases; each targeted 61 disease may require a specific probiotic property, which cannot be found in a 62 single probiotic strain [12] [13] [14] [15] . Multi-species probiotic products are therefore 63 now commonly available and although some have not shown superior 64 methods, although there are adaptations to these. The first is the observation 90 of growth of the species as whole organism co-cultures or bioproduct/species 91 co-culture on or within selective growth media; colony counting or 92 turbidimetric measurements are used to determine the degree of inhibition 93 Kingdom. The species were obtained as dehydrated cultures (the form in 120 which the species are introduced to make the final product, P1). 121
Growth conditions and maintenance of strains 122
The probiotic species were cultured overnight in de Man Rogosa Sharpe 123 
Cell free supernatant and microcalorimeter experiments 152
The cell free supernatant (CFS) obtained from each species was tested 153 against the producing organism and the other species. Culture supernatants 154 of the probiotic species were prepared by cultivating the respective species in 155 broth over 48 h anaerobically using an Oxoid anaerobic jar with an 156
AnaeroGen GasPak System (Oxoid, Basingstoke, UK). The cells were 157 removed by centrifuging at 3500 g for 10 min at 4 o C. The supernatant was 158 collected and filter-sterilized using a 0.22 µm membrane syringe filter. The 159 pHs of the supernatants were examined and recorded. It is important to note that the inoculum concentration for the species were the 182 same; while it would be possible to explore the effect of different inoculum 183 concentrations, the number of permutations and combinations would be vast.
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The time-lag before growth for some of the species may indicate a period of 185 adaptation of the species to the medium [36] . AUC also varied amongst the 186 species with E. faecium producing the highest heat output and L. acidophilus 187 the least. The maximum power attained was also higher for E. faecium 188 relative to the other species, which could imply that growth of E. faecium in 189 the medium is favoured or the species adapts to the medium more quickly 190 than the others. Growth of the species and P1 in MRSc, Figure 3 CFU/mL) were observed at the end of the IMC-CFS experiment with these 216 species relative to 10 7 CFU/mL for the others. It could be reasoned that the 217
CFS of L. plantarum and L. rhamnosus caused some cell death in L. 218 acidophilus and E. faecium. 219
According to the IMC data and plate count data, the CFS of L. plantarum was 220 the most inhibitory towards all the other species; that of E. faecium was the 221 least inhibitory. The CFS of L. rhamnosus was the most effective against L. 222 plantarum and had a greater capacity to inhibit other species than L. 223 acidophilus. The data also showed that the species were inhibited by their 224 own CFS, this being more profound in the case of L. acidophilus which had 225 lower final concentration of 10 6 CFU/mL unlike the other species, which 226 maintained cell count of 10 7 CFU/mL after incubation in their own CFS. 227
In this study, our goal was to explore the potential of IMC to determine 228 whether some probiotics could inhibit others in vitro. The data show that some 229 species inhibit others and therefore may consequently inhibit them when 230 blended together as a formulation. This observation is consistent with 231 previous findings of Be ' Lactococcus and Bacillus species tested, mutual inhibition was observed; 239 however the degree of inhibition was reported to be genus-specific. 240
Lactobacilli were reported to be most effective in inhibiting species of other 241 genera followed, by bifidobacteria. Bacillus, Streptococcus and Lactococcus 242 species showed little ability to inhibit species from the other genera. Testing 243 against strains of their own genus, they also reported that lactobacilli showed 244 mutual inhibition amongst the species [18], which is consistent with the 245 present findings. The inhibitory properties of lactobacilli may be due to the 246 production of acids and other metabolites to which they themselves are 247 susceptible. According to the present study, amongst the lactobacilli tested, L. 248 plantarum had the greatest capacity to inhibit other bacteria followed by L. 249 rhamnosus then L. acidophilus. The reason for the greater inhibitory profile of 250 L. plantarum could be either the production of greater quantity of antimicrobial 251 substances or a broader spectrum of activity of the antimicrobial substances 252 produced. Indeed CFS produced by L. plantarum recorded the lowest pH 253 indicating that it may have produced the highest quantity of acidic metabolites, 254 which may have contributed to its inhibitory profile. 255
The results from the study have several implications, not least of which is the 256 importance for research into intra and interspecies interaction of potential 257 probiotic strains and species and the need for their characterization before 258 they are put together as a product, submissions also echoed by Myllyluoma et 259
al. [38] when studying the effects of multispecies probiotic combinations on 260
Helicobacter pylori infection in vitro and Grandy et al.
[39] when studying two 261 different probiotic preparations for treatment of acute rotavirus diarrhoea [38, 262 39]. One likely consequence of species inhibition in combination products is 263 the probability that the species inhibited is the species offering the specific 264 activity anticipated. Also, species may adversely react or the presence of a 265 species could affect the potency of the other [18, 40] . 266
In conclusion, the results from this study show that some probiotic species 267 could be inhibitory to others and highlight the importance of characterizing 268 probiotic species before putting them together as combination products. 269 
